HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hitoshi Hori Selected Research

TX 2100

9/2010Medicinal electronomics bricolage design of hypoxia-targeting antineoplastic drugs and invention of boron tracedrugs as innovative future-architectural drugs.
6/2006The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
2/2006Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hitoshi Hori Research Topics

Disease

32Neoplasms (Cancer)
08/2014 - 03/2002
9Anoxia (Hypoxia)
08/2012 - 05/2002
4Inflammation
06/2008 - 11/2002
4Fever (Fevers)
02/2007 - 01/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2006 - 01/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2012 - 03/2004
3Neoplasm Metastasis (Metastasis)
10/2009 - 09/2005
2Breast Neoplasms (Breast Cancer)
08/2014 - 07/2013
2Cardiovascular Diseases (Cardiovascular Disease)
05/2014 - 01/2013
2Prostatic Neoplasms (Prostate Cancer)
07/2013 - 03/2009
2Ascites
07/2013 - 05/2002
1Prion Diseases (Transmissible Spongiform Encephalopathies)
08/2014
1Heart Diseases (Heart Disease)
08/2014
1Lewis Lung Carcinoma
07/2013
1Lung Neoplasms (Lung Cancer)
07/2013
1Colorectal Neoplasms (Colorectal Cancer)
07/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Colonic Neoplasms (Colon Cancer)
10/2009
1Rectal Neoplasms (Rectal Cancer)
10/2009
1Neurofibromatoses (Neurofibromatosis)
03/2009
1AIDS-Related Complex (ARC)
03/2009
1Peritonitis
06/2008
1Infection
11/2007
1Tuberculosis (Tuberculoses)
11/2007
1Necrosis
11/2006
1Chronic Obstructive Pulmonary Disease (COPD)
11/2006
1Granuloma
08/2006
1Brain Neoplasms (Brain Tumor)
02/2006

Drug/Important Bio-Agent (IBA)

9vitamin D-binding protein-macrophage activating factorIBA
08/2014 - 05/2002
7Bromodeoxyuridine (BrdU)IBA
01/2007 - 01/2003
6tirapazamine (SR 4233)IBA
09/2010 - 01/2003
6Cytochalasin BIBA
03/2006 - 01/2003
52-nitroimidazole acetamideIBA
10/2009 - 05/2002
5SuspensionsIBA
03/2006 - 01/2003
4BoronIBA
08/2014 - 12/2006
43-amino-2-quinoxalinecarbonitrileIBA
12/2006 - 11/2003
4CytotoxinsIBA
12/2006 - 05/2002
4SASIBA
03/2006 - 01/2003
3Proteins (Proteins, Gene)IBA
08/2014 - 11/2006
3Vitamin D-Binding ProteinIBA
07/2013 - 09/2004
3TX 2100IBA
09/2010 - 02/2006
3Propolis (Bee Bread)IBA
05/2009 - 07/2007
3artepillin CIBA
03/2009 - 07/2007
2EtanidazoleIBA
08/2014 - 01/2011
2AntioxidantsIBA
05/2014 - 05/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 11/2003
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2010 - 09/2008
2N-acetylcochinol-O-phosphateIBA
01/2007 - 08/2005
2DNA (Deoxyribonucleic Acid)IBA
12/2006 - 06/2005
2Cisplatin (Platino)FDA LinkGeneric
06/2005 - 01/2003
1Advanced Glycosylation End ProductsIBA
08/2014
1HormonesIBA
08/2014
1tin(IV) chlorin e6IBA
08/2014
1chlorin e6IBA
08/2014
1protoporphyrin IXIBA
08/2014
1VitaminsIBA
07/2013
1Cholecalciferol (Vitamin D3)FDA Link
07/2013
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
07/2013
1Sepharose (Agarose)IBA
07/2013
1MannosidasesIBA
07/2013
1Thioctic Acid (Lipoic Acid)IBA
07/2013
1LipidsIBA
01/2013
1Lipoproteins (Lipoprotein)IBA
01/2013
1Bovine Serum AlbuminIBA
01/2013
12- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA
08/2012
1Antineoplastic Agents (Antineoplastics)IBA
09/2010
1mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidaseIBA
03/2010
1Plasminogen Activators (Plasminogen Activator)IBA
10/2009
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2009
1caffeic acid phenethyl esterIBA
03/2009
1Phosphotransferases (Kinase)IBA
03/2009
1NF-kappa B (NF-kB)IBA
06/2008
1CarrageenanIBA
06/2008
1TX-1898IBA
12/2006
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2006
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2006
1Type II Tumor Necrosis Factor ReceptorsIBA
11/2006
1TNF-SAM2IBA
11/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2006
1polylactic acid-polyglycolic acid copolymer (PLGA)IBA
08/2006
1MisonidazoleIBA
03/2006
1NimorazoleIBA
03/2006
1mercaptoundecahydrododecaborate (borocaptate sodium)IBA
02/2006
1AntigensIBA
11/2005
1Actins (F Actin)IBA
11/2005
1Vitamin DFDA LinkGeneric
11/2005
1ChemokinesIBA
09/2005
1Carbon MonoxideIBA
08/2005
1Messenger RNA (mRNA)IBA
06/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2005
1Vincristine (Oncovin)FDA LinkGeneric
06/2005
1Dactinomycin (Ac-De)FDA LinkGeneric
06/2005

Therapy/Procedure

4Immunotherapy
08/2014 - 11/2005
4Heterologous Transplantation (Xenotransplantation)
10/2009 - 06/2005
4Boron Neutron Capture Therapy
12/2006 - 09/2004
2Drug Therapy (Chemotherapy)
05/2014 - 03/2010
2Therapeutics
03/2009 - 12/2006
2Microspheres (Microsphere)
11/2007 - 08/2006
1Aftercare (After-Treatment)
01/2012
1Radiotherapy
03/2006